149
Participants
Start Date
September 24, 2015
Primary Completion Date
August 23, 2023
Study Completion Date
February 16, 2024
bicalutamide + triptorelin
Cisplatin + Doxorubicin
Carboplatin + Paclitaxel
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels
Medical University Vienna - General Hospital AKH, Vienna
National Institute Of Oncology, Budapest
Cliniques Universitaires Saint-Luc, Brussels
ZNA Middelheim, Antwerp
Universitair Ziekenhuis Antwerpen, Edegem
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
Athens University - Attikon University General Hospital, Athens
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - Institut Claudius Regaud, Toulouse
CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux
Azienda Provinciale per i Servizi Sanitari - Ospedale Santa Chiara, Trento
Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
Assistance Publique - Hopitaux de Paris - Hopital Tenon, Paris
U.Z. Leuven - Campus Gasthuisberg, Leuven
Institut régional du Cancer Montpellier, Montpellier
CHU de Nantes - Hotel Dieu, Nantes
Gustave Roussy, Villejuif
Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden, Leipzig
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Radboud University Medical Center Nijmegen, Nijmegen
Centre Antoine Lacassagne, Nice
Universitaetsklinikum Jena-Radiation Therapy and Radiooncology Clinic, Jena
Spaarne Gasthuis - Vrije Universiteit Medisch Centrum, Amsterdam
University Medical Center Groningen (UMCG), Groningen
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK